Downloads: 1 | Views: 29 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Research Paper | Pharmacology Science | United States of America | Volume 9 Issue 11, November 2020 | Popularity: 4.6 / 10
The Digital Transformation of Pharmacovigilance: Enhancing Adverse Event Reporting Through Social Media and Apps
Vani Pathuri
Abstract: Pharmacovigilance plays a crucial role in ensuring drug safety, and the rise of digital technologies has transformed how adverse events (AEs) are reported and monitored. Social media, mobile applications, and digital platforms have enabled real - time data collection, yet challenges such as data reliability, regulatory inconsistencies, and integration with traditional systems remain. As global regulatory bodies adapt to digital AE reporting, there is a growing need to harmonize standards and improve patient engagement. This paper will explore the role of social media in AE reporting, the benefits of pharmacovigilance mobile apps, and the challenges limiting digital adoption. It will also examine global regulatory perspectives and successful case studies to highlight best practices in implementation. Additionally, future trends in digital pharmacovigilance, such as AI - driven analysis and blockchain security, will be discussed to outline the evolving landscape of drug safety monitoring. We propose a strategic approach to integrating digital pharmacovigilance tools with existing frameworks, leveraging emerging technologies to enhance efficiency, data accuracy, and regulatory compliance in adverse event reporting.
Keywords: Pharmacovigilance, adverse event reporting, digital health technology, drug safety monitoring, regulatory compliance, social media apps
Edition: Volume 9 Issue 11, November 2020
Pages: 1769 - 1773
DOI: https://www.doi.org/10.21275/SR20115082233
Please Disable the Pop-Up Blocker of Web Browser
Verification Code will appear in 2 Seconds ... Wait